insomnia in end-stage renal disease undergoing hemodialysis
Conditions
Sponsors
Beijing Dongcheng First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >= 18 years, male or female 2. Diagnosed with end-stage renal disease and chronic insomnia based on abovementioned diagnosis criteria 3. Insomnia Severity Index (ISI) >= 15 4. Maintenance hemodialysis treatment >= 3 months with stable condition 5. Agree to use zopiclone as rescue medicine 6. Written informed consent.
Exclusion criteria
Exclusion criteria: 1. Renal transplant patients 2. Having hemorrhagic disease, neurological disease, metabolic disease, hematopoietic system disease, infectious disease or other severe acute or chronic organic diseases 3. History of long-term use of sleeping pills before hemodialysis treatment 4. Having taken sleeping pills within 2 weeks before the first hemodialysis treatment 5. Having unstable toxuria complications such as water-electrolyte and acid-base disturbances, calcium and phosphorus metabolism disorders, cardiac insufficiency 6. Having undergone acupuncture therapy within 3 months 7. Having mental disorders or severe cognitive disorders 8. Pregnant or breastfeeding women 9. Having participated in other clinical trials within 3 months 10. Unable to cooperate or unwilling to comply with all study requirements 11. Cardiac pacemaker, metal allergy, or needle phobia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effective rate of sleep improvement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Insomnia Severity Idex;Pittsburgh sleep quality index;12-Item Short Form Survey;Fatigue severity scale;Sleep diary;Ambulatory blood pressure; | — |
Countries
China
Contacts
Public ContactLu Anming
Beijing Dongcheng First People's Hospital
Outcome results
None listed